The Medical Mind

In this special series from The Medical Mind podcast, we’re sharing select highlights from APA On Demand 2021, an online collection of expert-led presentations covering emerging clinical topics, cutting-edge science and new therapies.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

This special episode is co-presented by SMI Adviser, a Clinical Support System for Serious Mental Illness; and by NAMI, the National Alliance on Mental Illness. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association.

In this special series from The Medical Mind podcast, we’re sharing select highlights from APA On Demand 2020, an online collection of expert-led presentations covering emerging clinical topics, cutting-edge science and new therapies.

In this special series from The Medical Mind podcast, we’re sharing select highlights from APA On Demand 2020, an online collection of expert-led presentations covering emerging clinical topics, cutting-edge science and new therapies.

In this special series from The Medical Mind podcast, we’re sharing select highlights from APA On Demand 2020, an online collection of expert-led presentations covering emerging clinical topics, cutting-edge science and new therapies.

In this special series from The Medical Mind podcast, we’re sharing select highlights from APA On Demand 2020, an online collection of expert-led presentations covering emerging clinical topics, cutting-edge science and new therapies.

In this episode, Yuri Maricich of Pear Therapeutics and John Torous of the American Psychiatric Association's Health Information Technology Committee weigh in on mobile mental health apps: what’s new, what you need to know to evaluate an app, and what might be on the horizon. /episode/index/show/medicalmind/id/19736288

George Kolodner is the Founder of Kolmac Outpatient Recovery Centers. In 1973 he established the first intensive outpatient addiction treatment program, and he’s found that patients who receive withdrawal management in an outpatient setting are much more likely to continue with follow-up treatment. He discusses how he developed an alternative to inpatient rehab programs and the importance of continuity of care. /episode/index/show/medicalmind/id/19736291

Tim Brennan is director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke's hospitals. He discusses the why and how of transitioning a patient from methadone to buprenorphine, and dispels some common misperceptions that patients and providers have about these treatments. /episode/index/show/medicalmind/id/19736294

Lauren Carson, founder of Black Girls Smile, discusses her experience of mental health treatment, the risk factors that black girls face, and her efforts to improve mental health education and outreach. /episode/index/show/medicalmind/id/19736297

There’s a growing movement to get naloxone into the hands of people who use drugs, their friends and family members, and bystanders in a variety of settings. But its widespread availability didn’t happen overnight. Alex Walley of Boston University School of Medicine and Boston Medical Center explains how we got to this moment and where naloxone access fits into the larger picture of drug treatment. /episode/index/show/medicalmind/id/19736300

Only 10% of 12- to 17-year-olds in need of substance use treatment actually receive care. This is the same period when people are most likely to begin abusing drugs, and adolescent drug use is an important predictor of the development of a substance use disorder later in life. Amy Yule of Harvard Medical School explains what sets this population apart and how to approach treatment.

Hospitals and public health officials are increasingly motivated to initiate medication-assisted treatment in the hospital setting. Chris Welsh of the University of Maryland School of Medicine explains the advantages of this approach.  Information about the Providers’ Clinical Support System can be found at www.pcssNOW.org. /episode/index/show/medicalmind/id/19736309

At this year’s APA Annual Meeting, participants in the Mental Health Innovation Zone previewed some exciting developments in the prevention, diagnosis, and treatment of mental illness.